Literature DB >> 16575763

[Pheochromocytoma - chromaffin cell tumor].

Konrad Szosland1, Barbara Kopff, Andrzej Lewiński.   

Abstract

Pheochromocytoma is a rare tumor derived from chromaffin cells, which produces catecholamins. The presence of this tumor is considered a cause of secondary hypertension, arrhythmias, sweating and also, but very rarely, mental disorders. Update diagnostic methods of pheochromocytoma are summarized in this article. Pheochromocytoma also coexists with endocrinological syndroms, e.g. multiple endocrine neoplasia type 2 (MEN 2). Studies confirm genetic background of pheochromocytoma occurrence.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16575763

Source DB:  PubMed          Journal:  Endokrynol Pol        ISSN: 0423-104X            Impact factor:   1.582


  5 in total

Review 1.  Management of Pheochromocytomas and Paragangliomas: A Case-Based Review of Clinical Aspects and Perspectives.

Authors:  Bartosz Kamil Sobocki; Adrian Perdyan; Olga Szot; Jacek Rutkowski
Journal:  J Clin Med       Date:  2022-05-05       Impact factor: 4.964

2.  A spontaneous paraganglioma-pheochromocytoma syndrome.

Authors:  Sadegh Toutounchi; Ryszard Pogorzelski; Maciej Siński; Izabela Loń; Lukasz Zapała; Patryk Fiszer; Ewa Krajewska; Maciej Skórski
Journal:  Cent European J Urol       Date:  2014-01-27

3.  The effect of surgical treatment of phaeochromocytoma on concomitant arterial hypertension and diabetes mellitus in a single-centre retrospective study.

Authors:  Ryszard Pogorzelski; Sadegh Toutounchi; Ewa Krajewska; Patryk Fiszer; Marcin Łykowski; Łukasz Zapała; Małgorzata Szostek; Wawrzyniec Jakuczun; Janusz Pachucki; Maciej Skórski
Journal:  Cent European J Urol       Date:  2014-12-05

4.  Absence of an embryonic stem cell DNA methylation signature in human cancer.

Authors:  Ze Zhang; John K Wiencke; Devin C Koestler; Lucas A Salas; Brock C Christensen; Karl T Kelsey
Journal:  BMC Cancer       Date:  2019-07-19       Impact factor: 4.430

5.  From arterial hypertension complications to von Hippel-Lindau syndrome diagnosis.

Authors:  Sylwia Kozaczuk; Iwona Ben-Skowronek
Journal:  Ital J Pediatr       Date:  2015-08-13       Impact factor: 2.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.